eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. Please read our Terms of Service before submitting your own eLetter.
Research ArticleCancer
Overcoming adaptive therapy resistance in AML by targeting immune response pathways
- View ORCID ProfileKatelyn Melgar1,2,
- Morgan M. Walker3,
- View ORCID ProfileLaQuita M. Jones4,
- Lyndsey C. Bolanos1,
- View ORCID ProfileKathleen Hueneman1,
- View ORCID ProfileMark Wunderlich1,
- Jian-Kang Jiang3,
- View ORCID ProfileKelli M. Wilson3,
- Xiaohu Zhang3,
- Patrick Sutter3,
- Amy Wang3,
- Xin Xu3,
- View ORCID ProfileKwangmin Choi1,
- View ORCID ProfileGregory Tawa3,
- Donald Lorimer4,
- View ORCID ProfileJan Abendroth4,
- Eric O’Brien5,
- Scott B. Hoyt3,
- Ellin Berman6,
- Christopher A. Famulare7,
- James C. Mulloy1,
- Ross L. Levine6,7,8,
- View ORCID ProfileJohn P. Perentesis5,
- View ORCID ProfileCraig J. Thomas3,9,* and
- View ORCID ProfileDaniel T. Starczynowski1,10,*
- 1Division of Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229, USA.
- 2Immunology Graduate Program, Cincinnati Children’s Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.
- 3Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA.
- 4UCB Bainbridge, Bainbridge Island, WA 98110, USA.
- 5Division of Oncology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229, USA.
- 6Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
- 7Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
- 8Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
- 9Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20829, USA.
- 10Department of Cancer Biology, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA.
- ↵*Corresponding author. Email: craigt{at}mail.nih.gov (C.J.T.); daniel.starczynowski{at}cchmc.org (D.T.S.)
See allHide authors and affiliations
Science Translational Medicine 04 Sep 2019:
Vol. 11, Issue 508, eaaw8828
DOI: 10.1126/scitranslmed.aaw8828
Vol. 11, Issue 508, eaaw8828
DOI: 10.1126/scitranslmed.aaw8828
Katelyn Melgar
1Division of Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229, USA.
2Immunology Graduate Program, Cincinnati Children’s Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.
Morgan M. Walker
3Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA.
LaQuita M. Jones
4UCB Bainbridge, Bainbridge Island, WA 98110, USA.
Lyndsey C. Bolanos
1Division of Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229, USA.
Kathleen Hueneman
1Division of Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229, USA.
Mark Wunderlich
1Division of Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229, USA.
Jian-Kang Jiang
3Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA.
Kelli M. Wilson
3Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA.
Xiaohu Zhang
3Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA.
Patrick Sutter
3Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA.
Amy Wang
3Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA.
Xin Xu
3Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA.
Kwangmin Choi
1Division of Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229, USA.
Gregory Tawa
3Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA.
Donald Lorimer
4UCB Bainbridge, Bainbridge Island, WA 98110, USA.
Jan Abendroth
4UCB Bainbridge, Bainbridge Island, WA 98110, USA.
Eric O’Brien
5Division of Oncology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229, USA.
Scott B. Hoyt
3Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA.
Ellin Berman
6Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Christopher A. Famulare
7Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
James C. Mulloy
1Division of Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229, USA.
Ross L. Levine
6Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
7Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
8Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
John P. Perentesis
5Division of Oncology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229, USA.
Craig J. Thomas
3Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892, USA.
9Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20829, USA.
Daniel T. Starczynowski
1Division of Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229, USA.
10Department of Cancer Biology, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA.
Submit a Response to This Article
No eLetters have been published for this article.